ATA605477A - Verfahren zur herstellung von neuen o-(3-amino- 2-hydroxypropyl)-amidoximderivaten deren saeureadditionssalzen und deren optisch aktiven antipoden - Google Patents

Verfahren zur herstellung von neuen o-(3-amino- 2-hydroxypropyl)-amidoximderivaten deren saeureadditionssalzen und deren optisch aktiven antipoden

Info

Publication number
ATA605477A
ATA605477A AT605477A AT605477A ATA605477A AT A605477 A ATA605477 A AT A605477A AT 605477 A AT605477 A AT 605477A AT 605477 A AT605477 A AT 605477A AT A605477 A ATA605477 A AT A605477A
Authority
AT
Austria
Prior art keywords
amidoxim
hydroxypropyl
derivatives
amino
acid
Prior art date
Application number
AT605477A
Other languages
English (en)
Other versions
AT355554B (de
Inventor
Kalman Dipl-Ing Chem Takacs
Nagy Peter Dipl-Ing C Literati
Ilona Dipl-Ing Chem Kiss
Antal Dipl-Ing Chem Simay
Matyas Dr Szentivanyi
Sandor Dr Virag
Katalin Farago
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Priority to AT874178A priority Critical patent/AT361457B/de
Publication of ATA605477A publication Critical patent/ATA605477A/de
Application granted granted Critical
Publication of AT355554B publication Critical patent/AT355554B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/14Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
AT605477A 1976-08-27 1977-08-22 Verfahren zur herstellung von neuen o-(3-amino- 2-hydroxypropyl)-amidoxim-derivaten, deren saeureadditionssalzen und deren optisch aktiven antipoden AT355554B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT874178A AT361457B (de) 1976-08-27 1977-08-22 Verfahren zur herstellung von neuen o-(3-amino- -2-hydroxypropyl)-amidoxim-derivaten und deren saeureadditionssalzen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU76CI1682A HU177578B (en) 1976-08-27 1976-08-27 Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives

Publications (2)

Publication Number Publication Date
ATA605477A true ATA605477A (de) 1979-08-15
AT355554B AT355554B (de) 1980-03-10

Family

ID=10994625

Family Applications (1)

Application Number Title Priority Date Filing Date
AT605477A AT355554B (de) 1976-08-27 1977-08-22 Verfahren zur herstellung von neuen o-(3-amino- 2-hydroxypropyl)-amidoxim-derivaten, deren saeureadditionssalzen und deren optisch aktiven antipoden

Country Status (23)

Country Link
JP (1) JPS5350131A (de)
AT (1) AT355554B (de)
AU (1) AU521432B2 (de)
BE (1) BE858134A (de)
CA (1) CA1077506A (de)
CH (1) CH630344A5 (de)
CS (1) CS204008B2 (de)
DD (1) DD132433A5 (de)
DE (1) DE2738589A1 (de)
DK (1) DK150196C (de)
ES (1) ES462346A1 (de)
FI (1) FI68396C (de)
FR (1) FR2362845A1 (de)
GB (1) GB1582029A (de)
GR (1) GR63623B (de)
HU (1) HU177578B (de)
IL (1) IL52804A (de)
NL (1) NL187478C (de)
NO (1) NO144793C (de)
PL (1) PL107628B1 (de)
SE (1) SE435280B (de)
SU (1) SU730296A3 (de)
YU (2) YU202377A (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849522A (en) * 1983-11-03 1989-07-18 Merrell Dow Pharmaceuticals Novel alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
US5212314A (en) * 1983-11-03 1993-05-18 Merrell Dow Pharmaceuticals Inc. Alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
ZA848428B (en) * 1983-11-03 1985-06-26 Merrell Pharma Inc Novel alkoxyimino ether derivatives of 5-acyl-2(1h)-pyridiones
JPH01169445A (ja) * 1987-12-25 1989-07-04 Fuji Photo Film Co Ltd 焦点距離切換えカメラ
HU207988B (en) * 1988-10-20 1993-07-28 Biorex Kutato Fejlesztoe Kft Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
HUT54347A (en) * 1989-01-10 1991-02-28 Chinoin Gyogyszer Es Vegyeszet Improved process for producing amidoximes
HU222994B1 (hu) * 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
HUT78139A (hu) * 1995-12-22 2000-11-28 BIOREX Kutató és Fejlesztő Rt. Készítmény, különösen a bőr öregedési folyamatainak mérséklésére
AU766831B2 (en) 1998-05-11 2003-10-23 Takeda Pharmaceutical Company Limited Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity
WO2000007580A2 (en) * 1998-08-03 2000-02-17 N-Gene Kutató Kft. Pharmaceutical compositions against autoimmune diseases
AU2003202104B8 (en) 2002-01-11 2008-10-02 Cytrx Corporation Carboxamidine derivatives and their use in the treatment of vascular diseases
HUP0303584A3 (en) 2003-10-30 2009-12-28 Cytrx Corp Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
US20230416224A1 (en) 2020-11-19 2023-12-28 Zevra Denmark A/S Processes for preparing arimoclomol citrate and intermediates thereof

Also Published As

Publication number Publication date
FI68396B (fi) 1985-05-31
AU521432B2 (en) 1982-04-01
NO772958L (no) 1978-02-28
NO144793B (no) 1981-08-03
CH630344A5 (en) 1982-06-15
SU730296A3 (ru) 1980-04-25
IL52804A (en) 1981-06-29
DK150196C (da) 1987-07-06
HU177578B (en) 1981-11-28
CS204008B2 (en) 1981-03-31
FI772551A (fi) 1978-02-28
NO144793C (no) 1981-11-11
JPS6216942B2 (de) 1987-04-15
IL52804A0 (en) 1977-10-31
FR2362845A1 (fr) 1978-03-24
PL107628B1 (pl) 1980-02-29
NL7709276A (nl) 1978-03-01
DK379777A (da) 1978-02-28
AU2825477A (en) 1979-03-01
DE2738589A1 (de) 1978-03-02
JPS5350131A (en) 1978-05-08
ES462346A1 (es) 1978-06-16
YU202377A (en) 1983-12-31
YU237782A (en) 1983-12-31
DK150196B (da) 1987-01-05
SE435280B (sv) 1984-09-17
GR63623B (en) 1979-11-27
NL187478C (nl) 1991-10-16
DD132433A5 (de) 1978-09-27
GB1582029A (en) 1980-12-31
FI68396C (fi) 1985-09-10
BE858134A (fr) 1977-12-16
FR2362845B1 (de) 1981-01-09
AT355554B (de) 1980-03-10
SE7709482L (sv) 1978-02-28
CA1077506A (en) 1980-05-13

Similar Documents

Publication Publication Date Title
DD130477A5 (de) Verfahren zur herstellung von mercaptoacylaminosaeuren und deren salzen
AT357520B (de) Verfahren zur herstellung von neuen 2-phenyl-3- aroylbenzothiophenen und 2-phenyl-3- -aroylbenzothiophen-1-oxiden und von deren salzen
ATA41277A (de) Verfahren zur herstellung von neuen oximen der 7-aminothiazolylacetamidocephalosporansaeure und von deren salzen
AT375646B (de) Verfahren zur herstellung von neuen sulfonamidopyridinderivaten und deren salzen
ATA605477A (de) Verfahren zur herstellung von neuen o-(3-amino- 2-hydroxypropyl)-amidoximderivaten deren saeureadditionssalzen und deren optisch aktiven antipoden
AT353762B (de) Verfahren zur herstellung von neuen omega- aminocarbonsaeurederivaten und deren salzen
ATA182577A (de) Verfahren zur herstellung von neuen piperidin- derivaten und deren salzen
AT360972B (de) Verfahren zur herstellung von neuen amino- benzoesaeureamiden und deren salzen
ATA302677A (de) Verfahren zur herstellung von neuen 1,3-dihydro- heteroarylspiro/isobenzofuran)en und von deren optischen antipoden und pharmazeutisch vertraeglichen saeureadditionssalzen
AT351025B (de) Verfahren zur herstellung von neuen 1,4-dihydro -pyridinen und deren salzen
AT357558B (de) Verfahren zur herstellung von neuen (1,2- dihydro-2-oxo-nicotinamido)-alkyl-benzol- sulfonylharnstoffen und von deren salzen
ATA225277A (de) Verfahren zur herstellung von neuen benzaze- pinen und deren additionssalzen
AT340904B (de) Verfahren zur herstellung von neuen racemischen und optisch aktiven basischen glycinestern und deren salzen
ATA112277A (de) Verfahren zur herstellung von neuen 2,9-dioxa- tricyclo (4,3,1,03,7) decanen und deren salzen
ATA905176A (de) Verfahren zur herstellung von neuen n2- arylsulfonyl-l-argininamiden und deren salzen
AT377767B (de) Verfahren zur herstellung von neuen 4-aza-17subst.-5alpha-androstan-3-onen und deren pharmazeutisch verwendbaren salzen
AT353249B (de) Verfahren zur herstellung von neuen 3-phenoxy-2 -hydroxy-1-phenoxy- oder -1- phenylthioalkyl- amino-propanen und von deren saeureadditions- salzen
ATA491778A (de) Verfahren zur herstellung von neuen bicyclischen thia-diaza-verbindungen und von deren salzen und optisch aktiven isomren
ATA296479A (de) Verfahren zur herstellung von neuen (1,2- dihydro-2-oxo-nicotinamido)-alkylbenzolsul- fonylharnstoffen und von deren salzen
AT350519B (de) Verfahren zur herstellung von neuen omega- amino-alkoxycycloalkanen sowie deren saeure- additonssalzen
AT347956B (de) Verfahren zur herstellung von neuen chinol-2- on-4-yl-alkansaeuren und von deren basenadditionssalzen
ATA671878A (de) Verfahren zur herstellung von neuen 3-phenoxy-2 -hydroxy-1-phenoxy- oder -1- phenylthioalkyl- amino-proganen und von deren saeureadditions- salzen
ATA794078A (de) Verfahren zur herstellung von neuen piperidin- derivaten und deren salzen
AT346318B (de) Verfahren zur herstellung von neuen biphenylaethern und deren salzen
ATA665379A (de) Verfahren zur herstellung von neuen amino- benzoesaeurechinazolinonen und deren salzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee